PROVIDIED. This Core will provide genomic sequence data derived from NMDP patients and donors that will be used by other projects and cores in the design and implementation of appropriate experiments. Building on prior work sequencing MHC regions, we have determined the genomic sequence of a Killer cell Ig-like receptor (KIR) haplotype, representing a first step in deciphering haplotypic variation at KIR. Given genomic sequence data, which includes both gene content and second level allelic variation within coding and noncociing regions, it will be possible to develop detection methodologies amenable to the unique characteristics of this gene family that will allow for the direct determination of complete KIR haplotypes. With the aim of applying these developments to studies of the involvement of KIR in the outcome of marrow transplant specifically though the NMDP, and immune related genetic effects in general, in the context of this program project we propose to accomplish the following specific aims: 1) To identify and characterize new haplotypes and allelic polymorphisms in the killer cell Ig-like receptor (KIR) genomic locus. This will be accorriDlished by utilizing high-throughputgenomic sequenceanalysis of the complete KIR locus from multiple marrow donor and recipient derived cell line DNAs.
This aim will define the complete structureof sufficient numbers of KIR haplotypes to include a large majority of the relevant population. 2) To develop and define a set of reagents and technologies useful as mapping tools for the study of potential KIR-linked diseases. To accomplish this we will define and relate KIR haplotype frequencies, allelic linkage disequilibrium, recombination frequency, and location relative to existing and new genes within the NMDP population and from a spectrum of ethnic groups. This will allow us to select from the substantialKIR dataset we will build, in order to select an appropriate subset that will allow for the optimal discriminationof whole or major portions of KIR haplotypes. During the course of this grant, data will be exchanged between this core and other appropriate projects and cores in order to guide the choice of new haplotypes to be sequenced, and to direct the development and utilization of superior genotyping assays capable of moreprecisely genotyping KIR. These data will be simultaneously be made available to the interested scientific community through submissions through the database Core project.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA111412-05
Application #
7914188
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-08-01
Budget End
2010-07-31
Support Year
5
Fiscal Year
2009
Total Cost
$178,095
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Romee, Rizwan; Cooley, Sarah; Berrien-Elliott, Melissa M et al. (2018) First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation. Blood 131:2515-2527
Oh, Felix; Todhunter, Deborah; Taras, Elizabeth et al. (2018) Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin. Clin Pharmacol 10:113-121
Rashidi, Armin; Ebadi, Maryam; Said, Bassil et al. (2018) Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect. Am J Hematol :
Bachanova, Veronika; Sarhan, Dhifaf; DeFor, Todd E et al. (2018) Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells. Cancer Immunol Immunother 67:483-494
de Witte, Moniek A; Sarhan, Dhifaf; Davis, Zachary et al. (2018) Early Reconstitution of NK and ?? T Cells and Its Implication for the Design of Post-Transplant Immunotherapy. Biol Blood Marrow Transplant 24:1152-1162
Pugh, Jason L; Nemat-Gorgani, Neda; Norman, Paul J et al. (2018) Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage. J Immunol 200:1146-1158
Cichocki, Frank; Wu, Cheng-Ying; Zhang, Bin et al. (2018) ARID5B regulates metabolic programming in human adaptive NK cells. J Exp Med 215:2379-2395
Grzywacz, Bartosz; Moench, Laura; McKenna Jr, David et al. (2018) Natural Killer Cell Homing and Persistence in the Bone Marrow After Adoptive Immunotherapy Correlates With Better Leukemia Control. J Immunother :
Sarhan, Dhifaf; Hippen, Keli L; Lemire, Amanda et al. (2018) Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37. Cancer Immunol Res 6:766-775
Williams, Robin L; Cooley, Sarah; Bachanova, Veronika et al. (2018) Recipient T Cell Exhaustion and Successful Adoptive Transfer of Haploidentical Natural Killer Cells. Biol Blood Marrow Transplant 24:618-622

Showing the most recent 10 out of 108 publications